CYTOSORBENTS CORPORATION Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
CYTOSORBENTS CORPORATION (CTSO) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $1.50 million as of 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2026-03-30
- 2025-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $1.50M.
- 2025-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $2.10M.
- 2025-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $2.20M.
- 2025-03-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $2.27M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount as first filed |
|---|---|---|
| 2025-12-31 | $1.50M 10-K · filed 2026-03-30 | |
| 2025-09-30 | $2.10M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $2.20M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $2.27M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $3.00M 10-K · filed 2026-03-30 | $3.04M 10-K · filed 2025-03-31 |
| 2024-09-30 | $3.54M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $4.42M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $4.05M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $4.87M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $7.99M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $3.19M 10-Q · filed 2023-08-01 | |
| 2023-03-31 | $3.78M 10-Q · filed 2023-05-02 | |
| 2022-12-31 | $4.75M 10-K · filed 2023-03-09 | |
| 2022-09-30 | $5.47M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $4.10M 10-Q · filed 2022-08-02 | |
| 2022-03-31 | $6.07M 10-Q · filed 2022-05-03 | |
| 2021-12-31 | $5.93M 10-K · filed 2022-03-10 | |
| 2021-09-30 | $5.67M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $5.99M 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $5.30M 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $2.90M 10-K · filed 2021-03-09 | |
| 2020-09-30 | $3.23M 10-Q · filed 2020-11-04 | |
| 2020-06-30 | $3.76M 10-Q · filed 2020-08-04 | |
| 2020-03-31 | $3.30M 10-Q · filed 2020-05-05 | |
| 2019-12-31 | $3.10M 10-K · filed 2020-03-05 | |
| 2019-09-30 | $2.07M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $849.00K 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $800.00K 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $943.00K 10-K · filed 2019-03-07 | |
| 2018-09-30 | $926.00K 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $651.00K 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $764.00K 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $411.00K 10-K · filed 2018-03-08 | |
| 2017-09-30 | $470.00K 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $609.00K 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $466.00K 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $309.00K 10-K · filed 2017-03-03 | |
| 2016-09-30 | $399.00K 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $513.00K 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $333.00K 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $393.00K 10-K · filed 2016-03-09 | |
| 2015-09-30 | $426.00K 10-Q · filed 2015-11-13 | |
| 2015-06-30 | $406.00K 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $339.00K 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $389.00K 10-K · filed 2015-03-31 | |
| 2014-09-30 | $159.00K 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $196.00K 10-Q · filed 2014-08-12 | |
| 2014-03-31 | $186.00K 10-Q · filed 2014-05-14 | |
| 2013-12-31 | $86.00K 10-K · filed 2014-03-31 | |
| 2013-09-30 | $104.00K 10-Q · filed 2013-11-06 | |
| 2013-06-30 | $131.00K 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $115.00K 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $54.10K 10-K · filed 2013-04-03 | |
| 2012-09-30 | $70.00K 10-Q · filed 2012-11-21 | |
| 2012-06-30 | $42.00K 10-Q · filed 2012-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |